Table 3 Correlations among biomarkers of effect (n = 66)
Immunological biomarkers vs. Inflammatory biomarkers | |||||
IL-1β (pg mL− 1) | IL-6 (pg mL− 1) | IL-10 (pg mL− 1) | TNF-α (pg mL− 1) | INF-γ (μg mL− 1) | |
CD80 monocyte expression (%) | p > 0.05 | p > 0.05 | r = 0.28 (p < 0.05) | p > 0.05 | r = − 0.31 (p < 0.05) |
CD86 monocyte expression (%) | r = − 0.27 (p < 0.05) | r = − 0.29 (p < 0.05) | r = 0.28 (p < 0.05) | r = − 0.35 (p < 0.05) | r = − 0.42 (p < 0.001) |
Immunological biomarkers vs. Oxidative Stress biomarkers | |||||
PCO (nmol mg− 1 protein) | GST (U GST mg− 1 protein) | ||||
CD80 monocyte expression (%) | r = − 0.41 (p < 0.001) | p > 0.05 | |||
CD86 monocyte expression (%) | r = − 0.43 (p < 0.001) | p > 0.05 | |||
Oxidative Stress biomarkers vs. Inflammatory biomarkers | |||||
IL-1β (pg mL− 1) | IL-6 (pg mL− 1) | IL-10 (pg mL− 1) | TNF-α (pg mL− 1) | INF-γ (pg mL− 1) | |
PCO (nmol mg− 1 protein) | r = 0.51 (p < 0.001) | r = 0.49 (p < 0.001) | r = − 0.42 (p < 0.001) | r = 0.46 (p < 0.001) | r = 0.54 (p < 0.001) |
GST (U GST mg− 1 protein) | r = − 0.29 (p < 0.05) | r = − 0.28 (p < 0.05) | p > 0.05 | r = − 0.35 (p < 0.05) | r = − 0.39 (p < 0.001) |